US Consumer Sentiment Plunges to Record Low in May Amid Iran Conflict and Inflation Fears Alan Milburn Criticizes UK Welfare Spending on Youth as Shameful Amid Calls for Reform Ebola Outbreak in DRC Heightens Healthcare Resource Concerns Nurse Warns Chinas Robot Workforce Strategy Gains Traction Tesla Chief Raises Competitive Concerns DoubleDigit Earnings Growth May Not Prevent the Next Bear Market History Suggests Adani Group Companies Rally Recouping 150 Billion in Market Value PostHindenburg OceanFirst Financial Corp OCFC Q1 2026 Earnings EPS Beat Amid Flat Revenue and Muted Market Response ATAI Q1 2026 Earnings SmallerthanExpected Loss Boosts Sentiment Amid No Revenue Onity Group Inc ONIT Q1 2026 Earnings EPS Misses Consensus Estimates by Wide Margin Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises MBRX Q1 2026 Earnings EPS Misses Estimates as Development Costs Rise RRX Q1 2026 Earnings EPS Beats Estimates as Margins Improve Stock Slides Eaton Vance Global Dividend Income Fund ETG Holds Steady as YieldSeekers Maintain Support Energy Focus Inc EFOI Edges Higher on Light Trading Key Levels in Focus CHS Inc CHSCM Holds Steady Near Support as Price Action Remains RangeBound AECOM ACM Climbs 265 as Infrastructure Bet Drives Investor Enthusiasm SIFCO Industries SIF Dips 13 While Holding Above Key Support What Traders Should Watch Silicon Valley Turns to Mundane Businesses AI and Dealmaking Reshape Accounting Property Management LEGT Q1 2026 Earnings SPAC Reports Positive EPS Amid No Revenue Stock Slightly Up KLX Energy Services KLXE Declines 327 Tests Key Support Near 284 PATH Q1 2026 Earnings EPS Surges Past Estimates Stock Slips STLA Q1 2026 Earnings EPS Misses Estimates Sharply Stock Edges Higher Niagen Bioscience Inc NAGE Q1 2026 Earnings Modest EPS Beat Highlights Operational Discipline Amid Quiet Revenue Reporting Mercurys 52 Billion Valuation Marks 49 Surge Reinforcing Fintech Resilience DeepSeek Appears Unlikely to Derail US AI Leaders Market Panic May Be Overstated Marker Therapeutics Q1 2026 Earnings Loss Narrows as Clinical Progress Continues IMUX Q1 2026 Earnings Wider Loss Than Expected but Stock Gains on Pipeline Momentum